| SLATE GRITSTONE BIO, INC.
88030324 09 Jul 2018 | on 28 Jun 2022
| Conducting evaluations in the field of pharmaceuticals; pharmaceutical... Class 042 Class 042 Computer & Software Services & Scientific Services Conducting evaluations in the field of pharmaceuticals; pharmaceutical product development and evaluation services; pharmaceutical research and development; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients | | | GRANITE GRITSTONE BIO, INC.
87882746 18 Apr 2018 | on 28 Jun 2022
| healthcare,Conducting evaluations in the field of pharmaceuticals; pha... Class 042 Class 042 Computer & Software Services & Scientific Services healthcare Class 044 Class 044 Medical, Beauty & Agricultural Services Conducting evaluations in the field of pharmaceuticals; pharmaceutical product development and evaluation services; pharmaceutical research and development; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients | | | Logo Mark GRITSTONE BIO, INC.
87748391 09 Jan 2018 | on 07 Dec 2021
| next-generation sequencing (NGS) data processor; bioinformatics data p... Class 005 Class 005 Pharmaceutical Products The mark consists of 46 line segments radiating out from a natural sun stone shape design. Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products next-generation sequencing (NGS) data processor; bioinformatics data processor; downloadable computer software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry Class 042 Computer & Software Services & Scientific Services pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; vaccines; vaccine preparations
Class 044 Medical, Beauty & Agricultural Services Color is not claimed as a feature of the mark. | | | GRITSTONE GRITSTONE BIO, INC.
87748380 09 Jan 2018 | on 23 Nov 2021
| Providing temporary use of on-line nondownloadable software and applic... Class 005 Class 005 Pharmaceutical Products pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; vaccines; vaccine preparations Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products GRIT STONE Class 042 Computer & Software Services & Scientific Services healthcare
Class 044 Medical, Beauty & Agricultural Services Providing temporary use of on-line nondownloadable software and applications for genome analysis, developing personal treatment strategies for patients with diagnosed cancer; conducting early evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer; consulting services for others in the field of design, planning, and implementation of clinical trials; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice | | 
